Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Transplantation. 2016 Jan;100(1):141–146. doi: 10.1097/TP.0000000000000829

Figure 2.

Figure 2

Patient survival among a matched case controlled cohort of HIV+ and HIV− liver transplant recipients. HIV+ recipients were matched 1:10 with HIV− recipients on recipient age, race, BMI, MELD, HCV status, acute rejection; donor age and race, cold ischemia time, and year of transplant. Compared to appropriate matched HIV− controls, patient survival was statistically lower at 5 years [55.8% vs. 72.1%, p < 0.001] and 10 years [39.3% vs. 57.1%, p < 0.001] post–transplant [aHR=1.68; 95% CI=1.28–2.20, p = 0.0002].